Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Exon-based transcriptome profiling reveals genes that have prognostic impact on the survival of young high risk diffuse large B-cellYfollicular grade 3 lymphoma patients with dose-dense chemoimmunotherapy and CNS prophylaxis. Results from a Nordic Lymphoma Group phase II study

Autor: Koivula, S, Taskinen, M, Chen, P, Holte, H, Delabie, J, Karjalainen-Lindsberg, ML, Björkholm, M, Fluge, O, Pedersen, LM, Jerkeman, M, Eriksson, M, Hautaniemi, S, Leppa, S

Publikováno v: Koivula, S, Taskinen, M, Chen, P, Holte, H, Delabie, J, Karjalainen-Lindsberg, ML, Björkholm, M, Fluge, O, Pedersen, LM, Jerkeman, M, Eriksson, M, Hautaniemi, S & Leppa, S 2011, ' Exon-based transcriptome profiling reveals genes that have prognostic impact on the survival of young high risk diffuse large B-cellYfollicular grade 3 lymphoma patients with dose-dense chemoimmunotherapy and CNS prophylaxis. Results from a Nordic Lymphoma Group phase II study ', Blood, vol. 116, pp. 1281 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::3ba00ab9f6ff36f0b88783303622464d
https://portal.findresearcher.sdu.dk/da/publications/3247b4bd-1330-4337-8ec7-eb0b705475fd

Literature of Interest.

Publikováno v: Journal of Gemmology. 2024, Vol. 39 Issue 1, p94-98. 5p.

Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma.

Autor: Taskinen M; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland; Genome Scale Biology Program, University of Helsinki, Helsinki, Finland., Louhimo R; Genome Scale Biology Program, University of Helsinki, Helsinki, Finland., Koivula S; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland; Genome Scale Biology Program, University of Helsinki, Helsinki, Finland., Chen P; Genome Scale Biology Program, University of Helsinki, Helsinki, Finland., Rantanen V; Genome Scale Biology Program, University of Helsinki, Helsinki, Finland., Holte H; Department of Oncology, Oslo University Hospital, Oslo, Norway., Delabie J; Department of Pathology, Oslo University Hospital, Oslo, Norway., Karjalainen-Lindsberg ML; Department of Pathology, Haartman Institute, University of Helsinki, Helsinki, Finland., Björkholm M; Department of Medicine, Karolinska University Hospital, Stockholm, Sweden., Fluge Ø; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Pedersen LM; Department of Hematology, Odense University Hospital, Odense, Denmark., Fjordén K; Department of Oncology, Lund University Hospital, Lund, Sweden., Jerkeman M; Department of Oncology, Lund University Hospital, Lund, Sweden., Eriksson M; Department of Oncology, Lund University Hospital, Lund, Sweden., Hautaniemi S; Genome Scale Biology Program, University of Helsinki, Helsinki, Finland., Leppä S; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland; Genome Scale Biology Program, University of Helsinki, Helsinki, Finland.

Publikováno v: PloS one [PLoS One] 2014 Mar 13; Vol. 9 (3), pp. e91031. Date of Electronic Publication: 2014 Mar 13 (Print Publication: 2014).

Prognostic impact of protein kinase C beta II expression in R-CHOP-treated diffuse large B-cell lymphoma patients.

Autor: Riihijärvi S; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland., Koivula S, Nyman H, Rydström K, Jerkeman M, Leppä S

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2010 May; Vol. 23 (5), pp. 686-93. Date of Electronic Publication: 2010 Feb 26.